Chronic lead nephropathy.
D000328:Adult; D001842:Bone and Bones / Q000032:analysis; D002614:Chelating Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004492:Edetic Acid / Q000627:therapeutic use; D004781:Environmental Exposure; D005260:Female; D006073:Gout / Q000150:complications; D006801:Humans; D002479:Inclusion Bodies; D007668:Kidney / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000139:chemically induced* / Q000150:complications / Q000503:physiopathology; D007684:Kidney Tubules / Q000473:pathology; D007854:Lead / Q000032:analysis / Q000378:metabolism / Q000652:urine; D007855:Lead Poisoning / Q000150:complications* / Q000209:etiology / Q000473:pathology; D008297:Male; D010146:Pain; D013997:Time Factors; D014527:Uric Acid / Q000652:urine
D002614:Chelating Agents; D014527:Uric Acid; D007854:Lead; D004492:Edetic Acid